6634Sinew Pharma6634 info
$2.06info0.61%24h
Global rank19239
Market cap$144.88M
Change 7d-4.76%
YTD Performance-2.65%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Sinew Pharma (6634) Stock Overview

    Sinew Pharma Inc., a biopharmaceutical company, focuses on the development and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases. The company's products include SNP-610 drug, which is in Phase II clinical trial for treating patients with non-alcoholic steatohepatitis in Taiwan; and SNP-630, a pre-clinical drug for treating patients with non-alcoholic steatohepatitis. It is also developing SNP-810 for use in analgesic and antipyretic indications; and SNP-830 and SNP-840, which are used as hepatotoxicity-free analgesic medicines in the United States. The company was founded in 2014 and is based in Taipei City, Taiwan.

    6634 Stock Information

    Symbol
    6634
    Address
    C516, Building CTaipei, 11571Taiwan
    Founded
    -
    Trading hours
    -
    Website
    https://www.sinewpharma.com
    Country
    🇹🇼 Taiwan
    Phone Number
    886 2 2788 5365

    Sinew Pharma (6634) Price Chart

    -
    Value:-

    Sinew Pharma Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $2.06
    N/A
    Market Cap
    $144.88M
    N/A
    Shares Outstanding
    70.21M
    N/A
    Employees
    52.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org